Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | RPL38 |
| Upstream (Parents) |
|---|
| (<<) LOC222070 → RPL38 |
| (<<) EIF5B → RPL38 |
| Downstream (Children) |
|---|
| RPL38 → IL1RAPL1 (>>) |
| RPL38 → ATP1B2 (>>) |
| RPL38 → FKBP11 (>>) |
| RPL38 → LOC222070 (>>) |
| RPL38 → RPL27 (>>) |
| RPL38 → KCNAB3 (>>) |
| RPL38 → GPR182 (>>) |
| RPL38 → PEX6 (>>) |
| RPL38 → PDE4DIP (>>) |
| RPL38 → FKBP10 (>>) |
| RPL38 → AP1S1 (>>) |
| RPL38 → EIF5B (>>) |
| RPL38 → GSTM4 (>>) |
| RPL38 → PDE6D (>>) |
| RPL38 → PYGB (>>) |
| RPL38 → XRCC4 (>>) |
| RPL38 → SMPDL3B (>>) |
| RPL38 → BAT2L2 (>>) |
| RPL38 → MAP4K5 (>>) |
| RPL38 → PDK3 (>>) |
| RPL38 → DIMT1L (>>) |
| RPL38 → BST1 (>>) |
| RPL38 → ISL1 (>>) |
| RPL38 → MC5R (>>) |
| RPL38 → CLPB (>>) |
| RPL38 → PHF20L1 (>>) |
| RPL38 → CELA3A (>>) |
| RPL38 → MMP20 (>>) |
| RPL38 → ACAP2 (>>) |
| RPL38 → LSS (>>) |
| RPL38 → RAC3 (>>) |
| RPL38 → EPN2 (>>) |
| RPL38 → ANKRD12 (>>) |
| RPL38 → MED16 (>>) |
| RPL38 → ITFG2 (>>) |
| RPL38 → IBSP (>>) |
| RPL38 → MYO9B (>>) |
| RPL38 → TBL1Y (>>) |
| RPL38 → LOC100129502 (>>) |
| RPL38 → CNPY4 (>>) |
| RPL38 → BLK (>>) |
| RPL38 → CRYM (>>) |
| RPL38 → LAIR1 (>>) |
| RPL38 → GUCA1A (>>) |
| RPL38 → TRABD (>>) |
| RPL38 → PDK1 (>>) |
| RPL38 → PLCH2 (>>) |
| RPL38 → ECE2 (>>) |
| RPL38 → PDIA2 (>>) |
| RPL38 → ZNF500 (>>) |
| RPL38 → HOXD11 (>>) |
| RPL38 → SCD5 (>>) |
| RPL38 → APP (>>) |
| RPL38 → RPS19 (>>) |
| RPL38 → RPS11 (>>) |
| RPL38 → PRAMEF13///PRAMEF2///PRAMEF1 (>>) |
| RPL38 → PTGES (>>) |
| RPL38 → PCGF1 (>>) |
| RPL38 → PLEKHB2 (>>) |
| RPL38 → DUSP13 (>>) |
| RPL38 → CHMP4A (>>) |
